MK
Manmahesh Kantipudi
About Manmahesh Kantipudi
Data last updated:
Manmahesh Kantipudi is a Managing Director at Aragen Life Sciences Limited (since 2018), Director at Intox Private Limited (since 2023) and Director at Zeroharm Sciences Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Pharma, E-Commerce and Non-Profit Organizations. The 5 current companies with reported revenue have a combined latest revenue of ₹1,948 Cr; the largest is Aragen Life Sciences Limited at ₹1,870 Cr (FY 2025). Earlier, Manmahesh Kantipudi was a Director at Gxp Pharmaceuticals Private Limited (2013) and Additional Director at Young President's Organisation Hyderabad Chapter (2014–2015) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aragen Life Sciences Limited U74999TG2000PLC035826 | Managing Director | 29 May 2018 | 2000 | ₹1,870 Cr (FY 2025) | Active |
 Intox Private Limited U74999PN2000PTC015116 | Director | 25 Apr 2023 | 2000 | ₹45.44 Cr (FY 2025) | Active |
 Zeroharm Sciences Private Limited U24100TG2020PTC145072 | Director | 21 Dec 2021 | 2020 | ₹26.08 Cr (FY 2025) | Active |
 Aragen Biologics Private Limited U21001TS2023PTC174243 | Director | 21 Jun 2023 | 2023 | ₹3.37 Cr (FY 2025) | Active |
| Aragen Foundation U85300DL2021NPL391515 | Director | 21 Dec 2021 | 2021 | ₹2.59 Cr (FY 2025) | Active |
 Precisionrna Biotech Private Limited U74900TS2024PTC191157 | Director | 20 Nov 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gxp Pharmaceuticals Private Limited U85191PN2011PTC156428 | Director | 20 Mar 2013 | 2011 | ₹12,000 (FY 2023) | Active |
| Young President's Organisation Hyderabad Chapter U93000TG2007NPL055534 | Additional Director | 29 Jun 2014 | 2007 | ₹4.52 Cr (FY 2026) | Active |
| Inogent Laboratories Private Limited U24239TG2005PTC046402 | Director | 14 Mar 2016 | 2005 | ₹207 Cr (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manmahesh Kantipudi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manmahesh Kantipudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manmahesh Kantipudi
Manmahesh Kantipudi currently holds 6 directorships: Aragen Life Sciences Limited (Managing Director, since 29 May 2018, revenue ₹1,870 Cr (FY 2025)); Intox Private Limited (Director, since 25 Apr 2023, revenue ₹45.44 Cr (FY 2025)); Zeroharm Sciences Private Limited (Director, since 21 Dec 2021, revenue ₹26.08 Cr (FY 2025)); Aragen Biologics Private Limited (Director, since 21 Jun 2023, revenue ₹3.37 Cr (FY 2025)); Aragen Foundation (Director, since 21 Dec 2021, revenue ₹2.59 Cr (FY 2025)); and 1 more.
Manmahesh Kantipudi was first appointed on 20 Mar 2013 as Director at Gxp Pharmaceuticals Private Limited. The most recent appointment on record is 20 Nov 2024 at Precisionrna Biotech Private Limited.
The 5 current companies of Manmahesh Kantipudi that report revenue have a combined latest revenue of ₹1,948 Cr: Aragen Life Sciences Limited ₹1,870 Cr (FY 2025); Intox Private Limited ₹45.44 Cr (FY 2025); Zeroharm Sciences Private Limited ₹26.08 Cr (FY 2025); Aragen Biologics Private Limited ₹3.37 Cr (FY 2025); Aragen Foundation ₹2.59 Cr (FY 2025).
Manmahesh Kantipudi held 3 earlier board appointments: Gxp Pharmaceuticals Private Limited (Director, 20 Mar 2013 to 29 Oct 2013); Young President's Organisation Hyderabad Chapter (Additional Director, 29 Jun 2014 to 30 Sep 2015); Inogent Laboratories Private Limited (Director, from 14 Mar 2016).
The current boards of Manmahesh Kantipudi's companies include Ajay Srivastava (Aragen Life Sciences Limited), Amit Varma (Aragen Life Sciences Limited), Anita Ramachandran (Aragen Life Sciences Limited), Davinder Singh Brar (Aragen Life Sciences Limited), Gunapati Reddy Venkat Keshav (Aragen Life Sciences Limited), Rajat Sood (Aragen Life Sciences Limited), among others.